CLVT - Clarivate Plc
After hours:
| Previous close | 8.48 |
| Open | 8.43 |
| Bid | 8.18 x 29200 |
| Ask | 8.42 x 3200 |
| Day's range | 8.24 - 8.53 |
| 52-week range | 7.16 - 14.99 |
| Volume | |
| Avg. volume | 5,701,425 |
| Market cap | 5.67B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.52 |
| Earnings date | 07 Aug 2023 - 11 Aug 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.06 |
ZacksWall Street Analysts Predict a 54.5% Upside in Clarivate PLC (CLVT): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 54.5% in Clarivate PLC (CLVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CNW GroupClarivate and IPwe to Provide Financial Valuations and Business Insights for IP Assets
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the integration of the Smart Intangible Asset Management (SIAM) solution from IPwe Inc. into IPfolio™. This integration will enable IPfolio users to access unique patent valuation metrics from SIAM, including real-time, objective financial benchmarks on a patent-by-patent and portfolio basis, alongside competitor and peer portfolio metrics. It
CNW GroupClarivate Launches New Artificial Intelligence Tools to Enable Trademark Professionals to Assess Brand Risk from Every Angle
Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of the Clarivate Brand Landscape Analyzer and the development of the Clarivate Trademark Watch Analyzer. Together they will enable brand professionals to assess brand risk from every angle as they make trademark intelligence more actionable.
ZacksWill Clarivate PLC (CLVT) Beat Estimates Again in Its Next Earnings Report?
Clarivate PLC (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PR Newswire AsiaClarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director
Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.
- CNW Group
Clarivate and KAIST Innovation Strategy and Policy Institute Release Report on the Global AI Chip Innovation Landscape
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform the world, and the KAIST Innovation Strategy and Policy Institute (ISPI), a top research institution in South Korea today launched a collaborative report on the global innovation landscape of the artificial intelligence (AI) chip industry. The report suggests it is crucial to build an innovation ecosystem to stimulate mutual-cooperation among universities, enterprises and
- CNW Group
Clarivate Names Top 100 Global Innovators 2023
Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Top 100 Global Innovators™ – companies and organizations which sit at the very top of the global innovation ecosystem, with the most consistent above-the-bar innovation performance.
ZacksClarivate PLC (CLVT) Upgraded to Strong Buy: Here's What You Should Know
Clarivate PLC (CLVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- CNW Group
Clarivate Adds Preprint Citation Index to the Web of Science
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, has added the Preprint Citation Index™ to the Web of Science™ platform. Researchers can now locate and link to preprints alongside other trusted content in the database, to streamline the research process and help make meaningful connections faster.
CNW GroupBioWorld by Clarivate Rethinks Obesity in New Special Investigation, Finding Fitness May Be More Linked to Health than Weight
BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, explores how difficult scientific detachment can be for health topics that have large cultural components- such as obesity. After many years of research and development, drug-induced weight loss has matured into a viable therapeutic option. Special investigation from BioWorld provides in-depth analysis of the latest advances in metaboli
ZacksHow Much Upside is Left in Clarivate PLC (CLVT)? Wall Street Analysts Think 39.2%
The mean of analysts' price targets for Clarivate PLC (CLVT) points to a 39.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- CNW Group
Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch™ report. In its 10th year, the Drugs to Watch report provides in-depth predictive analysis of drugs with the potential to transform treatment paradigms and serve unmet patient needs. The report serves as a key industry resource in an ever-evolving drug innovation landscape - with more than 70 drugs having been iden
- CNW Group
Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 165 Research Fronts
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, and the Chinese Academy of Sciences (CAS) today released Research Fronts 2022, their ninth annual collaborative report. The report identifies significant areas in the world of sciences and social sciences as to where the scientific community is focusing its attention, including several COVID-related fronts and areas mirrored by the research fields of Noble Prize in rece
- CNW Group
Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the inclusion of linked specialty pharmacy claims data within real world data solutions. The new U.S. dataset will expand the real world data and analytics offerings from Clarivate. Researchers can access an in-depth view of high-cost medications and valuable insights into the patient's treatment journey in chronic, complex and rare diseases, such as rhe
- CNW Group
Clarivate Annual G20 Scorecard Report Reveals Insights into World's Leading Research Economies
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched its annual report which examines the research performance of each of the members of the G20 with a visual comparative snapshot for each.
ZacksIs the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
- CNW Group
Clarivate Partners with IPwe to Enhance AI and Blockchain Patent Solutions
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a strategic partnership with IPwe Inc., a leader in blockchain technology that provides smart solutions for the management of intangible assets through data-driven recommendations. The vision of this partnership is to enable Clarivate and IPwe customers to accelerate innovation through accessing uniquely curated patent data from Clarivate within IPwe's ar
- CNW Group
Clarivate Names World's Influential Researchers with Highly Cited Researchers 2022 List
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today revealed its 2022 list of Highly Cited Researchers™ – individuals at universities, research institutes and commercial organizations who have demonstrated a disproportionate level of significant and broad influence in their field or fields of research. The methodology draws on data from the Web of Science™ citation index, together with analysis performed by bibliom
- CNW Group
Clarivate and OCLC Settle Lawsuit
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has signed a settlement agreement and release with OCLC.
- CNW Group
Clarivate Successfully Completes Divestiture of MarkMonitor to Newfold Digital
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation today announced that it has successfully completed the divestiture of MarkMonitor™, an industry-leading enterprise-level provider of domain management solutions, to Newfold Digital ("Newfold"), a leading web and commerce technology provider backed by affiliates of Clearlake Capital Group, L.P. ("Clearlake") and Siris Capital Group, LLC ("Siris"). Previously, Clarivate ann
- CNW Group
Clarivate Identifies the Role of Research and Innovation in the World's Shift to Sustainable Energy
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report, A study of energy in transition: the role of research and innovation in the world's shift to sustainable energy sources. It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces. This finding is based on Clarivate data normalized
- CNW Group
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, RNA Technology Companies to Watch. The report identifies seven emerging innovators in the field of medical science who are solving for undruggable disease targets. The report draws on data and analytics from BioWorld, an award-winning suite of news services delivering actionable intelligence on the most innovative therapeutics
- CNW Group
Clarivate Global Research Report Examines Role of Research Assessment with a Review of Six Regional Systems
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released an in-depth look at formal regional research assessment, co-authored by the Institute for Scientific Information at Clarivate, together with esteemed industry partners: Kate Williams, University of Melbourne; Jonathan Grant, Different Angles; Lutz Bornmann, Max Planck Institute and Martin Szomszor, Electric Data Solutions.
- CNW Group
Clarivate Experts Celebrate 2022 Nobel Success with Seven Laureates Identified via Citation Analysis
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the seven new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ several years before being named by the Nobel Assembly – four, more than a decade – thanks to expert interpretation of high-quality citation data at
- CNW Group
Clarivate Supports Peer Review Week by Raising the Profile of Peer Reviewers
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates Peer Review Week with the announcement of new services for authors to better track their peer review activity. This includes academic publications, citation metrics and journal editing, now all in one place within the newly launched Web of Science™ Researcher Profiles.
